药物代谢动力学 (Chinese Wikipedia)

Analysis of information sources in references of the Wikipedia article "药物代谢动力学" in Chinese language version.

refsWebsite

Global rank Chinese rank

27doi.org

2^nd place

23^rd place

22nih.gov

4^th place

5^th place

14web.archive.org

1^st place

4semanticscholar.org

11^th place

332^nd place

4worldcat.org

5^th place

12^th place

3harvard.edu

18^th place

57^th place

2books.google.com

3^rd place

8^th place

1agah.eu

low place

1unil.ch

9,112^th place

6,188^th place

1springer.com

274^th place

320^th place

1wiley.com

222^nd place

216^th place

1sciencedirect.com

149^th place

292^nd place

1vcclab.org

low place

1nature.com

234^th place

227^th place

1europa.eu

68^th place

209^th place

1handle.net

102^nd place

492^nd place

1archive.org

6^th place

4^th place

1revistanefrologia.com

low place

1lww.com

2,769^th place

1,362^nd place

1epa.gov

882^nd place

1,116^th place

1who.int

195^th place

179^th place

1ecotoxmodels.org

low place

agah.eu

AGAH working group PHARMACOKINETICS. Collection of terms, symbols, equations, and explanations of common pharmacokinetic and pharmacodynamic parameters and some statistical functions (PDF). Arbeitsgemeinschaft für Angewandte Humanpharmakologie (AGAH) (Association for Applied Human Pharmacology). 2004-02-16 [2011-04-04]. （原始内容 (PDF)存档于2016-05-08）.

archive.org

Sheiner LB, Beal S, Rosenberg B, Marathe VV. Forecasting individual pharmacokinetics. Clinical Pharmacology and Therapeutics. September 1979, 26 (3): 294–305. PMID 466923. S2CID 41194071. doi:10.1002/cpt1979263294.

books.google.com

Weiner D, Gabrielsson J. PK24 – Non-linear kinetics – flow II. Pharmacokinetic/pharmacodynamic data analysis: concepts and applications. Apotekarsocieteten. 2000: 527–36 [2023-05-10]. ISBN 91-86274-92-9. （原始内容存档于2023-01-25）.
Joaquín Herrera Carranza Manual de farmacia clínica y Atención Farmacéutica (in Spanish).

doi.org

Ruiz-Garcia A, Bermejo M, Moss A, Casabo VG. Pharmacokinetics in drug discovery. Journal of Pharmaceutical Sciences. February 2008, 97 (2): 654–90. PMID 17630642. doi:10.1002/jps.21009.
International Union of Biochemistry (now International Union of Biochemistry and Molecular Biology). Symbolism and terminology in enzyme kinetics. Recommendations 1981. Biochem. J. 1982, 213 (3): 561–571. PMC 1152169 . PMID 6615450. doi:10.1042/bj2130561.
Cornish-Bowden, A. Current IUBMB recommendations on enzyme nomenclature and kinetics. Perspectives in Science. 2014, 1 (1–6): 74–87. Bibcode:2014PerSc...1...74C. doi:10.1016/j.pisc.2014.02.006.
International Union of Biochemistry (now International Union of Biochemistry and Molecular Biology). Symbolism and terminology in enzyme kinetics. Recommendations 1981. Eur. J. Biochem. 1982, 128 (2–3): 281–291. doi:10.1111/j.1432-1033.1982.tb06963.x .
Stroppolo ME, Falconi M, Caccuri AM, Desideri A. Superefficient enzymes. Cellular and Molecular Life Sciences. September 2001, 58 (10): 1451–1460. PMID 11693526. S2CID 24874575. doi:10.1007/PL00000788.
Bar-Even A, Noor E, Savir Y, Liebermeister W, Davidi D, Tawfik DS, Milo R. The moderately efficient enzyme: evolutionary and physicochemical trends shaping enzyme parameters. Biochemistry. May 2011, 50 (21): 4402–4410. PMID 21506553. doi:10.1021/bi2002289.
Copeland RA. Why Enzymes as Drug Targets? Enzyme are Essential for Life. Evaluation of Enzyme Inhibitors in Drug Discovery: A Guide for Medicinal Chemists and Pharmacologists Second. John Wiley & Sons, Inc. March 2013: 1–23. ISBN 978-1-118-48813-3. doi:10.1002/9781118540398.ch1.
International Union of Biochemistry (now International Union of Biochemistry and Molecular Biology). Symbolism and terminology in enzyme kinetics. Recommendations 1981. Arch. Biochem. Biophys. 1983, 234 (2): 732–740. doi:10.1016/0003-9861(83)90262-X.
Roila, Fausto; Del Favero, Albano. Ondansetron Clinical Pharmacokinetics. Clinical Pharmacokinetics. 1995-08-01, 29 (2): 95–109 [2023-05-13]. ISSN 1179-1926. doi:10.2165/00003088-199529020-00004. （原始内容存档于2023-05-13）（英语）.
Yang, Si H.; Lee, Myung G. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability. Biopharmaceutics & Drug Disposition. 2008-10, 29 (7): 414–426 [2023-05-13]. doi:10.1002/bdd.628. （原始内容存档于2023-05-13）（英语）.
Di, Li; Kerns, Edward H. Profiling drug-like properties in discovery research. Current Opinion in Chemical Biology. 2003-06-01, 7 (3): 402–408 [2023-05-08]. ISSN 1367-5931. doi:10.1016/S1367-5931(03)00055-3 （英语）.
Tetko IV, Bruneau P, Mewes HW, Rohrer DC, Poda GI. Can we estimate the accuracy of ADME-Tox predictions? (PDF). Drug Discovery Today. August 2006, 11 (15–16): 700–707 [2023-05-02]. PMID 16846797. doi:10.1016/j.drudis.2006.06.013. （原始内容 (pre-print)存档于2013-09-12）.
Leeson, Paul D.; Springthorpe, Brian. The influence of drug-like concepts on decision-making in medicinal chemistry. Nature Reviews Drug Discovery. 2007-11, 6 (11): 881–890 [2023-05-08]. ISSN 1474-1784. doi:10.1038/nrd2445. （原始内容存档于2023-01-28）（英语）.
Baaske P, Wienken CJ, Reineck P, Duhr S, Braun D. Optical thermophoresis for quantifying the buffer dependence of aptamer binding. Angewandte Chemie. March 2010, 49 (12): 2238–41. PMID 20186894. doi:10.1002/anie.200903998.
Wienken CJ, Baaske P, Rothbauer U, Braun D, Duhr S. Protein-binding assays in biological liquids using microscale thermophoresis. Nature Communications. October 2010, 1 (7): 100. Bibcode:2010NatCo...1..100W. PMID 20981028. doi:10.1038/ncomms1093 .
Hsieh Y, Korfmacher WA. Increasing speed and throughput when using HPLC-MS/MS systems for drug metabolism and pharmacokinetic screening. Current Drug Metabolism. June 2006, 7 (5): 479–89. PMID 16787157. S2CID 13612670. doi:10.2174/138920006777697963.
Covey TR, Lee ED, Henion JD. High-speed liquid chromatography/tandem mass spectrometry for the determination of drugs in biological samples. Analytical Chemistry. October 1986, 58 (12): 2453–60. PMID 3789400. doi:10.1021/ac00125a022.
Covey TR, Crowther JB, Dewey EA, Henion JD. Thermospray liquid chromatography/mass spectrometry determination of drugs and their metabolites in biological fluids. Analytical Chemistry. February 1985, 57 (2): 474–81. PMID 3977076. doi:10.1021/ac50001a036.
Li, Xue; Martinez-Lozano Sinues, Pablo; Dallmann, Robert; Bregy, Lukas; Hollmén, Maija; Proulx, Steven; Brown, Steven A.; Detmar, Michael; Kohler, Malcolm; Zenobi, Renato. Drug Pharmacokinetics Determined by Real-Time Analysis of Mouse Breath. Angewandte Chemie International Edition. 2015-06-26, 54 (27): 7815–7818. PMID 26015026. doi:10.1002/anie.201503312. hdl:20.500.11850/102558  （英语）.
Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. Journal of Pharmacokinetics and Biopharmaceutics. October 1977, 5 (5): 445–79. PMID 925881. S2CID 28622472. doi:10.1007/BF01061728.
Sheiner LB, Beal S, Rosenberg B, Marathe VV. Forecasting individual pharmacokinetics. Clinical Pharmacology and Therapeutics. September 1979, 26 (3): 294–305. PMID 466923. S2CID 41194071. doi:10.1002/cpt1979263294.
Bonate PL. Recommended reading in population pharmacokinetic pharmacodynamics. The AAPS Journal. October 2005, 7 (2): E363–73. PMC 2750974 . PMID 16353916. doi:10.1208/aapsj070237.
Singh SS. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. Current Drug Metabolism. February 2006, 7 (2): 165–182. PMID 16472106. doi:10.2174/138920006775541552.
Naesens, Maarten; Kuypers, Dirk R. J.; Sarwal, Minnie. Calcineurin Inhibitor Nephrotoxicity. Clinical Journal of the American Society of Nephrology. 2009-02, 4 (2): 481 [2023-05-13]. ISSN 1555-9041. doi:10.2215/CJN.04800908. （原始内容存档于2023-07-10）.
Robert N, Wong GW, Wright JM. Effect of cyclosporine on blood pressure. Cochrane Database of Systematic Reviews. January 2010, (1): CD007893. PMID 20091657. doi:10.1002/14651858.CD007893.pub2.
Jager T, Albert C, Preuss TG, Ashauer R. General unified threshold model of survival--a toxicokinetic-toxicodynamic framework for ecotoxicology. Environmental Science & Technology. April 2011, 45 (7): 2529–40. Bibcode:2011EnST...45.2529J. PMID 21366215. doi:10.1021/es103092a.
Tucker GT. Research priorities in pharmacokinetics. British Journal of Clinical Pharmacology. June 2012, 73 (6): 924–6. PMC 3391520 . PMID 22360418. doi:10.1111/j.1365-2125.2012.04238.x.

ecotoxmodels.org

Ashauer R. Toxicokinetic-Toxicodynamic Models – Ecotoxicology and Models. Swiss Federal Institute of Aquatic Science and Technology. [2011-12-03]. （原始内容存档于2012-04-05）.

epa.gov

US EPA, OMS. Chemicals and Toxics Topics. www.epa.gov. 2016-11-17 [2022-05-15]. （原始内容存档于2023-09-22）（英语）.

europa.eu

ema.europa.eu

Committee for Medicinal Products for Human Use (CHMP). ICH guideline M3(R2) on non-clinical safety studies for the conduct of human clinical trials and marketing authorisation for pharmaceuticals (PDF). European Medicines Agency, Evaluation of Medicines for Human Use. December 2009 [4 May 2013]. EMA/CPMP/ICH/286/1995. （原始内容存档 (PDF)于2018-06-15）.

handle.net

hdl.handle.net

Li, Xue; Martinez-Lozano Sinues, Pablo; Dallmann, Robert; Bregy, Lukas; Hollmén, Maija; Proulx, Steven; Brown, Steven A.; Detmar, Michael; Kohler, Malcolm; Zenobi, Renato. Drug Pharmacokinetics Determined by Real-Time Analysis of Mouse Breath. Angewandte Chemie International Edition. 2015-06-26, 54 (27): 7815–7818. PMID 26015026. doi:10.1002/anie.201503312. hdl:20.500.11850/102558  （英语）.

harvard.edu

ui.adsabs.harvard.edu

Cornish-Bowden, A. Current IUBMB recommendations on enzyme nomenclature and kinetics. Perspectives in Science. 2014, 1 (1–6): 74–87. Bibcode:2014PerSc...1...74C. doi:10.1016/j.pisc.2014.02.006.
Wienken CJ, Baaske P, Rothbauer U, Braun D, Duhr S. Protein-binding assays in biological liquids using microscale thermophoresis. Nature Communications. October 2010, 1 (7): 100. Bibcode:2010NatCo...1..100W. PMID 20981028. doi:10.1038/ncomms1093 .
Jager T, Albert C, Preuss TG, Ashauer R. General unified threshold model of survival--a toxicokinetic-toxicodynamic framework for ecotoxicology. Environmental Science & Technology. April 2011, 45 (7): 2529–40. Bibcode:2011EnST...45.2529J. PMID 21366215. doi:10.1021/es103092a.

lww.com

journals.lww.com

Naesens, Maarten; Kuypers, Dirk R. J.; Sarwal, Minnie. Calcineurin Inhibitor Nephrotoxicity. Clinical Journal of the American Society of Nephrology. 2009-02, 4 (2): 481 [2023-05-13]. ISSN 1555-9041. doi:10.2215/CJN.04800908. （原始内容存档于2023-07-10）.

nature.com

Leeson, Paul D.; Springthorpe, Brian. The influence of drug-like concepts on decision-making in medicinal chemistry. Nature Reviews Drug Discovery. 2007-11, 6 (11): 881–890 [2023-05-08]. ISSN 1474-1784. doi:10.1038/nrd2445. （原始内容存档于2023-01-28）（英语）.

nih.gov

ncbi.nlm.nih.gov

Ruiz-Garcia A, Bermejo M, Moss A, Casabo VG. Pharmacokinetics in drug discovery. Journal of Pharmaceutical Sciences. February 2008, 97 (2): 654–90. PMID 17630642. doi:10.1002/jps.21009.
Hallare, Jericho; Gerriets, Valerie, Half Life, StatPearls (Treasure Island (FL): StatPearls Publishing), 2021 [2021-12-25], PMID 32119385, （原始内容存档于2023-03-24）
International Union of Biochemistry (now International Union of Biochemistry and Molecular Biology). Symbolism and terminology in enzyme kinetics. Recommendations 1981. Biochem. J. 1982, 213 (3): 561–571. PMC 1152169 . PMID 6615450. doi:10.1042/bj2130561.
Stroppolo ME, Falconi M, Caccuri AM, Desideri A. Superefficient enzymes. Cellular and Molecular Life Sciences. September 2001, 58 (10): 1451–1460. PMID 11693526. S2CID 24874575. doi:10.1007/PL00000788.
Bar-Even A, Noor E, Savir Y, Liebermeister W, Davidi D, Tawfik DS, Milo R. The moderately efficient enzyme: evolutionary and physicochemical trends shaping enzyme parameters. Biochemistry. May 2011, 50 (21): 4402–4410. PMID 21506553. doi:10.1021/bi2002289.
Drug Bioavailability Gary Price Deven A. Patel In: StatPearls.Treasure Island(FL): StatPearls Publishing; 2023 Jan. PMID 32496732 Bookshelf ID: NBK557852 2022 Jun 23.
Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability. Yang SH, Lee MG. Biopharm Drug Dispos. 2008 Oct;29(7):414-26.doi:10.1002/bdd.628.PMID 18697186
Tetko IV, Bruneau P, Mewes HW, Rohrer DC, Poda GI. Can we estimate the accuracy of ADME-Tox predictions? (PDF). Drug Discovery Today. August 2006, 11 (15–16): 700–707 [2023-05-02]. PMID 16846797. doi:10.1016/j.drudis.2006.06.013. （原始内容 (pre-print)存档于2013-09-12）.
Baaske P, Wienken CJ, Reineck P, Duhr S, Braun D. Optical thermophoresis for quantifying the buffer dependence of aptamer binding. Angewandte Chemie. March 2010, 49 (12): 2238–41. PMID 20186894. doi:10.1002/anie.200903998.
Wienken CJ, Baaske P, Rothbauer U, Braun D, Duhr S. Protein-binding assays in biological liquids using microscale thermophoresis. Nature Communications. October 2010, 1 (7): 100. Bibcode:2010NatCo...1..100W. PMID 20981028. doi:10.1038/ncomms1093 .
Hsieh Y, Korfmacher WA. Increasing speed and throughput when using HPLC-MS/MS systems for drug metabolism and pharmacokinetic screening. Current Drug Metabolism. June 2006, 7 (5): 479–89. PMID 16787157. S2CID 13612670. doi:10.2174/138920006777697963.
Covey TR, Lee ED, Henion JD. High-speed liquid chromatography/tandem mass spectrometry for the determination of drugs in biological samples. Analytical Chemistry. October 1986, 58 (12): 2453–60. PMID 3789400. doi:10.1021/ac00125a022.
Covey TR, Crowther JB, Dewey EA, Henion JD. Thermospray liquid chromatography/mass spectrometry determination of drugs and their metabolites in biological fluids. Analytical Chemistry. February 1985, 57 (2): 474–81. PMID 3977076. doi:10.1021/ac50001a036.
Li, Xue; Martinez-Lozano Sinues, Pablo; Dallmann, Robert; Bregy, Lukas; Hollmén, Maija; Proulx, Steven; Brown, Steven A.; Detmar, Michael; Kohler, Malcolm; Zenobi, Renato. Drug Pharmacokinetics Determined by Real-Time Analysis of Mouse Breath. Angewandte Chemie International Edition. 2015-06-26, 54 (27): 7815–7818. PMID 26015026. doi:10.1002/anie.201503312. hdl:20.500.11850/102558  （英语）.
Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. Journal of Pharmacokinetics and Biopharmaceutics. October 1977, 5 (5): 445–79. PMID 925881. S2CID 28622472. doi:10.1007/BF01061728.
Sheiner LB, Beal S, Rosenberg B, Marathe VV. Forecasting individual pharmacokinetics. Clinical Pharmacology and Therapeutics. September 1979, 26 (3): 294–305. PMID 466923. S2CID 41194071. doi:10.1002/cpt1979263294.
Bonate PL. Recommended reading in population pharmacokinetic pharmacodynamics. The AAPS Journal. October 2005, 7 (2): E363–73. PMC 2750974 . PMID 16353916. doi:10.1208/aapsj070237.
Singh SS. Preclinical pharmacokinetics: an approach towards safer and efficacious drugs. Current Drug Metabolism. February 2006, 7 (2): 165–182. PMID 16472106. doi:10.2174/138920006775541552.
Robert N, Wong GW, Wright JM. Effect of cyclosporine on blood pressure. Cochrane Database of Systematic Reviews. January 2010, (1): CD007893. PMID 20091657. doi:10.1002/14651858.CD007893.pub2.
Jager T, Albert C, Preuss TG, Ashauer R. General unified threshold model of survival--a toxicokinetic-toxicodynamic framework for ecotoxicology. Environmental Science & Technology. April 2011, 45 (7): 2529–40. Bibcode:2011EnST...45.2529J. PMID 21366215. doi:10.1021/es103092a.
Tucker GT. Research priorities in pharmacokinetics. British Journal of Clinical Pharmacology. June 2012, 73 (6): 924–6. PMC 3391520 . PMID 22360418. doi:10.1111/j.1365-2125.2012.04238.x.

gateway.nlm.nih.gov

Gill SC, Moon-Mcdermott L, Hunt TL, Deresinski S, Blaschke T, Sandhaus RA. Phase I Pharmacokinetics of Liposomal Amikacin (MiKasome) in Human Subjects: Dose Dependence and Urinary Clearance. Abstr Intersci Conf Antimicrob Agents Chemother. Sep 1999, 39: 33 (abstract no. 1195) [2023-05-10]. （原始内容存档于2011-11-23）.

revistanefrologia.com

O'Valle, F.; García del Moral, R.; Andujar, M. Mecanismos de nefrotoxicidad por ciclosporina A a nivel celular. Nefrologia. 1995,. 15 Supplement 1 [2023-05-10]. （原始内容存档于2018-07-26）（西班牙语）.

sciencedirect.com

Di, Li; Kerns, Edward H. Profiling drug-like properties in discovery research. Current Opinion in Chemical Biology. 2003-06-01, 7 (3): 402–408 [2023-05-08]. ISSN 1367-5931. doi:10.1016/S1367-5931(03)00055-3 （英语）.

semanticscholar.org

api.semanticscholar.org

Stroppolo ME, Falconi M, Caccuri AM, Desideri A. Superefficient enzymes. Cellular and Molecular Life Sciences. September 2001, 58 (10): 1451–1460. PMID 11693526. S2CID 24874575. doi:10.1007/PL00000788.
Hsieh Y, Korfmacher WA. Increasing speed and throughput when using HPLC-MS/MS systems for drug metabolism and pharmacokinetic screening. Current Drug Metabolism. June 2006, 7 (5): 479–89. PMID 16787157. S2CID 13612670. doi:10.2174/138920006777697963.
Sheiner LB, Rosenberg B, Marathe VV. Estimation of population characteristics of pharmacokinetic parameters from routine clinical data. Journal of Pharmacokinetics and Biopharmaceutics. October 1977, 5 (5): 445–79. PMID 925881. S2CID 28622472. doi:10.1007/BF01061728.
Sheiner LB, Beal S, Rosenberg B, Marathe VV. Forecasting individual pharmacokinetics. Clinical Pharmacology and Therapeutics. September 1979, 26 (3): 294–305. PMID 466923. S2CID 41194071. doi:10.1002/cpt1979263294.

springer.com

link.springer.com

Roila, Fausto; Del Favero, Albano. Ondansetron Clinical Pharmacokinetics. Clinical Pharmacokinetics. 1995-08-01, 29 (2): 95–109 [2023-05-13]. ISSN 1179-1926. doi:10.2165/00003088-199529020-00004. （原始内容存档于2023-05-13）（英语）.

unil.ch

sepia.unil.ch

Pharmacokinetics Online Resource University of Lausanne Faculty of Biology and Medicine (FBM)

vcclab.org

Tetko IV, Bruneau P, Mewes HW, Rohrer DC, Poda GI. Can we estimate the accuracy of ADME-Tox predictions? (PDF). Drug Discovery Today. August 2006, 11 (15–16): 700–707 [2023-05-02]. PMID 16846797. doi:10.1016/j.drudis.2006.06.013. （原始内容 (pre-print)存档于2013-09-12）.

web.archive.org

AGAH working group PHARMACOKINETICS. Collection of terms, symbols, equations, and explanations of common pharmacokinetic and pharmacodynamic parameters and some statistical functions (PDF). Arbeitsgemeinschaft für Angewandte Humanpharmakologie (AGAH) (Association for Applied Human Pharmacology). 2004-02-16 [2011-04-04]. （原始内容 (PDF)存档于2016-05-08）.
Hallare, Jericho; Gerriets, Valerie, Half Life, StatPearls (Treasure Island (FL): StatPearls Publishing), 2021 [2021-12-25], PMID 32119385, （原始内容存档于2023-03-24）
Gill SC, Moon-Mcdermott L, Hunt TL, Deresinski S, Blaschke T, Sandhaus RA. Phase I Pharmacokinetics of Liposomal Amikacin (MiKasome) in Human Subjects: Dose Dependence and Urinary Clearance. Abstr Intersci Conf Antimicrob Agents Chemother. Sep 1999, 39: 33 (abstract no. 1195) [2023-05-10]. （原始内容存档于2011-11-23）.
Weiner D, Gabrielsson J. PK24 – Non-linear kinetics – flow II. Pharmacokinetic/pharmacodynamic data analysis: concepts and applications. Apotekarsocieteten. 2000: 527–36 [2023-05-10]. ISBN 91-86274-92-9. （原始内容存档于2023-01-25）.
Roila, Fausto; Del Favero, Albano. Ondansetron Clinical Pharmacokinetics. Clinical Pharmacokinetics. 1995-08-01, 29 (2): 95–109 [2023-05-13]. ISSN 1179-1926. doi:10.2165/00003088-199529020-00004. （原始内容存档于2023-05-13）（英语）.
Yang, Si H.; Lee, Myung G. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability. Biopharmaceutics & Drug Disposition. 2008-10, 29 (7): 414–426 [2023-05-13]. doi:10.1002/bdd.628. （原始内容存档于2023-05-13）（英语）.
Tetko IV, Bruneau P, Mewes HW, Rohrer DC, Poda GI. Can we estimate the accuracy of ADME-Tox predictions? (PDF). Drug Discovery Today. August 2006, 11 (15–16): 700–707 [2023-05-02]. PMID 16846797. doi:10.1016/j.drudis.2006.06.013. （原始内容 (pre-print)存档于2013-09-12）.
Leeson, Paul D.; Springthorpe, Brian. The influence of drug-like concepts on decision-making in medicinal chemistry. Nature Reviews Drug Discovery. 2007-11, 6 (11): 881–890 [2023-05-08]. ISSN 1474-1784. doi:10.1038/nrd2445. （原始内容存档于2023-01-28）（英语）.
Committee for Medicinal Products for Human Use (CHMP). ICH guideline M3(R2) on non-clinical safety studies for the conduct of human clinical trials and marketing authorisation for pharmaceuticals (PDF). European Medicines Agency, Evaluation of Medicines for Human Use. December 2009 [4 May 2013]. EMA/CPMP/ICH/286/1995. （原始内容存档 (PDF)于2018-06-15）.
O'Valle, F.; García del Moral, R.; Andujar, M. Mecanismos de nefrotoxicidad por ciclosporina A a nivel celular. Nefrologia. 1995,. 15 Supplement 1 [2023-05-10]. （原始内容存档于2018-07-26）（西班牙语）.
Naesens, Maarten; Kuypers, Dirk R. J.; Sarwal, Minnie. Calcineurin Inhibitor Nephrotoxicity. Clinical Journal of the American Society of Nephrology. 2009-02, 4 (2): 481 [2023-05-13]. ISSN 1555-9041. doi:10.2215/CJN.04800908. （原始内容存档于2023-07-10）.
US EPA, OMS. Chemicals and Toxics Topics. www.epa.gov. 2016-11-17 [2022-05-15]. （原始内容存档于2023-09-22）（英语）.
Chemical safety. www.who.int. [2022-05-15]. （原始内容存档于2023-05-11）（英语）.
Ashauer R. Toxicokinetic-Toxicodynamic Models – Ecotoxicology and Models. Swiss Federal Institute of Aquatic Science and Technology. [2011-12-03]. （原始内容存档于2012-04-05）.

who.int

Chemical safety. www.who.int. [2022-05-15]. （原始内容存档于2023-05-11）（英语）.

wiley.com

onlinelibrary.wiley.com

Yang, Si H.; Lee, Myung G. Dose-independent pharmacokinetics of ondansetron in rats: contribution of hepatic and intestinal first-pass effects to low bioavailability. Biopharmaceutics & Drug Disposition. 2008-10, 29 (7): 414–426 [2023-05-13]. doi:10.1002/bdd.628. （原始内容存档于2023-05-13）（英语）.

worldcat.org

Roila, Fausto; Del Favero, Albano. Ondansetron Clinical Pharmacokinetics. Clinical Pharmacokinetics. 1995-08-01, 29 (2): 95–109 [2023-05-13]. ISSN 1179-1926. doi:10.2165/00003088-199529020-00004. （原始内容存档于2023-05-13）（英语）.
Di, Li; Kerns, Edward H. Profiling drug-like properties in discovery research. Current Opinion in Chemical Biology. 2003-06-01, 7 (3): 402–408 [2023-05-08]. ISSN 1367-5931. doi:10.1016/S1367-5931(03)00055-3 （英语）.
Leeson, Paul D.; Springthorpe, Brian. The influence of drug-like concepts on decision-making in medicinal chemistry. Nature Reviews Drug Discovery. 2007-11, 6 (11): 881–890 [2023-05-08]. ISSN 1474-1784. doi:10.1038/nrd2445. （原始内容存档于2023-01-28）（英语）.
Naesens, Maarten; Kuypers, Dirk R. J.; Sarwal, Minnie. Calcineurin Inhibitor Nephrotoxicity. Clinical Journal of the American Society of Nephrology. 2009-02, 4 (2): 481 [2023-05-13]. ISSN 1555-9041. doi:10.2215/CJN.04800908. （原始内容存档于2023-07-10）.